BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3117976)

  • 1. Ganglioside GM1 causes expression of type B monoamine oxidase in a rat clonal pheochromocytoma cell line, PC12h.
    Naoi M; Suzuki H; Takahashi T; Shibahara K; Nagatsu T
    J Neurochem; 1987 Nov; 49(5):1602-5. PubMed ID: 3117976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific binding of glycosylated beta-galactosidase to rat clonal pheochromocytoma PC12h cells: effects of nerve growth factor and gangliosides.
    Naoi M; Shibahara K; Suzuki H; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1297-301. PubMed ID: 3126266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of N-methyl-4-phenylpyridinium ion on monoamine oxidase in a clonal rat pheochromocytoma cell line, PC12h.
    Naoi M; Suzuki H; Kiuchi K; Takahashi T; Nagatsu T
    J Neurochem; 1987 Jun; 48(6):1912-6. PubMed ID: 2883261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    Neurosci Lett; 1987 Jun; 77(2):215-20. PubMed ID: 3601232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    J Neurochem; 1988 Jan; 50(1):243-7. PubMed ID: 3335842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
    Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM
    J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM1 ganglioside treatment of PC12 cells stimulates ganglioside, glycolipid, and lipid, but not glycoprotein synthesis independently from the effects of nerve growth factor.
    Katoh-Semba R; Skaper SD; Varon S
    J Neurochem; 1986 Feb; 46(2):574-82. PubMed ID: 3941320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds.
    Naoi M; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1105-10. PubMed ID: 3346669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase in rat and bovine endocrine tissues.
    Lenzen S; Freisinger-Treichel M; Panten U
    J Neurochem; 1987 Oct; 49(4):1183-90. PubMed ID: 3305788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of GM1 ganglioside with PC12 pheochromocytoma cells: serum- and NGF-dependent effects on neuritic growth (and proliferation).
    Katoh-Semba R; Skaper SD; Varon S
    J Neurosci Res; 1984; 12(2-3):299-310. PubMed ID: 6502755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve growth factor-mediated stimulation of tyrosine hydroxylase activity in a clonal rat pheochromocytoma cell line.
    Hatanaka H
    Brain Res; 1981 Oct; 222(2):225-33. PubMed ID: 6116517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some characteristics of monoamine oxidase activity in tissues of the adult female grassfrog (Rana pipiens).
    UrueƱa G; Hall TR
    Comp Biochem Physiol C Comp Pharmacol; 1982; 73(1):67-70. PubMed ID: 6128181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple forms of monoamine oxidase in developing chick brain.
    Suzuki O; Katsumata Y; Oya M; Asano M
    Dev Neurosci; 1978; 1(3-4):172-6. PubMed ID: 756381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of synephrine by type A and type B monoamine oxidase.
    Suzuki O; Matsumoto T; Oya M; Katsumata Y
    Experientia; 1979 Oct; 35(10):1283-4. PubMed ID: 499398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
    Riederer P; Youdim MB
    J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of a Ca(2+)-dependent protein kinase by GM1 ganglioside in nerve growth factor-treated PC12 cells.
    Hilbush BS; Levine JM
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5616-20. PubMed ID: 1676513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deamination of aliphatic amines of different chain lengths by rat liver monoamine oxidase A and B.
    Yu PH
    J Pharm Pharmacol; 1989 Mar; 41(3):205-8. PubMed ID: 2568453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential localization of monoamine oxidase type A activity in neurons of the locus coeruleus and type B activity in neurons of the dorsal raphe nucleus of the rat: a detailed enzyme histochemical study.
    Arai R; Kimura H; Nagatsu I; Maeda T
    Brain Res; 1997 Jan; 745(1-2):352-6. PubMed ID: 9037433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase in bovine thyroid tissue.
    Masini-Repiso AM; Cabanillas AM; Andrada MC; Coleoni AH
    Horm Metab Res; 1986 Nov; 18(11):750-3. PubMed ID: 3098663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.